Forced coexpression of the transcription factors Oct3/4, Klf4, Sox2, and c-Myc reprograms somatic cells into pluripotent stem cells (PSCs). Such induced PSCs (iPSCs) can generate any cell type of the adult body or indefinitely proliferate without losing their potential. Accordingly, iPSCs can serve as an unlimited cell source for the development of various disease models and regenerative therapies for animals and humans. Although canine peripheral blood mononuclear cells (PBMCs) can be easily obtained, they have a very low iPSC reprogramming efficiency. In this study, we determined the reprogramming efficiency of canine PBMCs under several conditions involving three types of media supplemented with small-molecule compounds. We found that canine iPSCs (ciPSCs) could be efficiently generated from PBMCs using N2B27 medium supplemented with leukemia inhibitory factor (LIF), basic fibroblast growth factor (bFGF), and a small-molecule cocktail (Y-27632, PD0325901, CHIR99021, A-83-01, Forskolin, and l-ascorbic acid). We generated five ciPSC lines that could be maintained in StemFit® medium supplemented with LIF. The SeVdp(KOSM)302L vectors were appropriately silenced in four ciPSC lines. Of the two lines characterized, both were positive for alkaline phosphatase activity and expressed pluripotency markers, including the Oct3/4, Sox2, and Nanog transcripts, as well as the octamer-binding transcription factor (OCT) 3/4 and NANOG proteins, and the SSEA-1 carbohydrate antigen. The ciPSCs could form embryoid bodies and differentiate into the three germ layers, as indicated by marker gene and protein expression. Furthermore, one ciPSC line formed teratomas comprising several tissues from every germ layer. Our ciPSC lines maintained a normal karyotype even after multiple passages. Moreover, our new reprogramming method was able to generate ciPSCs from multiple donor PBMCs. In conclusion, we developed an easy and efficient strategy for the generation of footprint-free ciPSCs from PBMCs. We believe that this strategy can be useful for disease modeling and regenerative medicine in the veterinary field.
Get full access to this article
View all access options for this article.
References
1.
ThomsonJA, Itskovitz-EldorJ, ShapiroSS, WaknitzMA, SwiergielJJ, MarshallVS and JonesJM. (1998). Embryonic stem cell lines derived from human blastocysts. Science, 282:1145–1147.
2.
TakahashiK and YamanakaS. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126:663–676.
3.
TakahashiK, TanabeK, OhnukiM, NaritaM, IchisakaT, TomodaK and YamanakaS. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131:861–872.
4.
MandaiM, WatanabeA, KurimotoY, HiramiY, MorinagaC, DaimonT, FujiharaM, AkimaruH, SakaiN, et al. (2017). Autologous induced stem-cell-derived retinal cells for macular degeneration. N Engl J Med, 376:1038–1046.
5.
SonMY, SimH, SonYS, JungKB, LeeMO, OhJH, ChungSK, JungCR and KimJ. (2017). Distinctive genomic signature of neural and intestinal organoids from familial Parkinson's disease patient-derived induced pluripotent stem cells. Neuropathol Appl Neurobiol, 43:584–603.
6.
LingaasF, AarskaugT, SlettenM, BjerkåsI, GrimholtU, MoeL, JunejaRK, WiltonAN, GalibertF, HolmesNG and DolfG. (1998). Genetic markers linked to neuronal ceroid lipofuscinosis in English setter dogs. Anim Genet, 29:371–376.
7.
OllierWE, KennedyLJ, ThomsonW, BarnesAN, BellSC, BennettD, AnglesJM, InnesJF and CarterSD. (2001). Dog MHC alleles containing the human RA shared epitope confer susceptibility to canine rheumatoid arthritis. Immunogenetics, 53:669–673.
8.
LinL, FaracoJ, LiR, KadotaniH, RogersW, LinX, QiuX, de JongPJ, NishinoS and MignotE. (1999). The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell, 98:365–376.
9.
BettsDH and TobiasIC. (2015). Canine pluripotent stem cells: are they ready for clinical applications?. Front Vet Sci, 2:41.
10.
ShimadaH, NakadaA, HashimotoY, ShigenoK, ShionoyaY and NakamuraT. (2010). Generation of canine induced pluripotent stem cells by retroviral transduction and chemical inhibitors. Mol Reprod Dev, 77:2.
11.
LeeAS, XuD, PlewsJR, NguyenPK, NagD, LyonsJK, HanL, HuS, LanF, et al. (2011). Preclinical derivation and imaging of autologously transplanted canine induced pluripotent stem cells. J Biol Chem, 286:32697–32704.
12.
LuoJ, SuhrST, ChangEA, WangK, RossPJ, NelsonLL, VentaPJ, KnottJG and CibelliJB. (2011). Generation of leukemia inhibitory factor and basic fibroblast growth factor-dependent induced pluripotent stem cells from canine adult somatic cells. Stem Cells Dev, 20:1669–1678.
13.
WhitworthDJ, OvchinnikovDA and WolvetangEJ. (2012). Generation and characterization of LIF-dependent canine induced pluripotent stem cells from adult dermal fibroblasts. Stem Cells Dev, 21:2288–2297.
14.
KohS, ThomasR, TsaiS, BischoffS, LimJH, BreenM, OlbyNJ and PiedrahitaJA. (2013). Growth requirements and chromosomal instability of induced pluripotent stem cells generated from adult canine fibroblasts. Stem Cells Dev, 22:951–963.
15.
NishimuraT, HatoyaS, KanegiR, SugiuraK, WijewardanaV, KuwamuraM, TanakaM, YamateJ, IzawaT, et al. (2013). Generation of functional platelets from canine induced pluripotent stem cells. Stem Cells Dev, 22:2026–2035.
16.
BairdA, BarsbyT and GuestDJ. (2015). Derivation of canine induced pluripotent stem cells. Reprod Domest Anim, 50:669–676.
17.
GonçalvesNJ, BressanFF, RoballoKC, MeirellesFV, XavierPL, FukumasuH, WilliamsC, BreenM, KohS, et al. (2017). Generation of LIF-independent induced pluripotent stem cells from canine fetal fibroblasts. Theriogenology, 92:75–82.
18.
OkitaK, IchisakaT and YamanakaS. (2007). Generation of germline-competent induced pluripotent stem cells. Nature, 448:313–317.
19.
TsukamotoM, NishimuraT, YodoeK, KanegiR, TsujimotoY, MdEA, KuramochiM, KuwamuraM, OhtakaM, et al. (2018). Generation of footprint-free canine induced pluripotent cells using auto-erasable sendai virus vector. Stem Cells Dev, 27:1577–1585.
20.
NishimuraK, OhtakaM, TakadaH, KurisakiA, TranNVK, TranYTH, HisatakeK, SanoM and NakanishiM. (2017). Simple and effective generation of transgene-free induced pluripotent stem cells using an auto-erasable Sendai virus vector responding to microRNA-302. Stem Cell Res, 23:13–19.
21.
NishimuraK, SanoM, OhtakaM, FurutaB, UmemuraY, NakajimaY, IkeharaY, KobayashiT, SegawaH, et al. (2011). Development of defective and persistent Sendai virus vector: a unique gene delivery/expression system ideal for cell reprogramming. J Biol Chem, 286:4760–4771.
22.
ChurkoJM, BurridgePW and WuJC. (2013). Generation of human iPSCs from human peripheral blood mononuclear cells using non-integrative Sendai virus in chemically defined conditions. Methods Mol Biol, 1036:81–88.
23.
OkumuraT, HorieY, LaiCY, LinHT, ShodaH, NatsumotoB, FujioK, KumakiE, OkanoT, et al. (2019). Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34+ cells using the auto-erasable Sendai virus vector. Stem Cell Res Ther, 10:185.
24.
SekiT, YuasaS and FukudaK. (2012). Generation of induced pluripotent stem cells from a small amount of human peripheral blood using a combination of activated T cells and Sendai virus. Nat Protoc, 7:718–728.
25.
TaylorCJ, PeacockS, ChaudhryAN, BradleyJA and BoltonEM. (2012). Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types. Cell Stem Cell, 11:147–152.
26.
TsukamotoM, KimuraK, TanakaM, KuwamuraM, OhtakaM, NakanishiM, SugiuraK and HatoyaS. (2020). Generation of footprint-free canine induced pluripotent stem cells from peripheral blood mononuclear cells using sendai virus vector. Mol Reprod Dev, 87:663–665.
27.
YuJ, ChauKF, VodyanikMA, JiangJ and JiangY. (2011). Efficient feeder-free episomal reprogramming with small molecules. PLos One, 6:1–10.
28.
Bar-NurO, BrumbaughJ, VerheulC, ApostolouE, Pruteanu-MaliniciI, WalshRM, RamaswamyS and HochedlingerK. (2014). Small molecules facilitate rapid and synchronous iPSC generation. Nat Methods, 11:1170–1176.
29.
WangYS, ChiKH, LiaoKW, LiuCC, ChengCL, LinYC, ChengCH and ChuRM. (2007). Characterization of canine monocyte-derived dendritic cells with phenotypic and functional differentiation. Can J Vet Res, 71:165–174.
30.
BuganimY, FaddahDA and JaenischR. (2013). Mechanisms and models of somatic cell reprogramming. Nat Rev Genet, 14:427–439.
31.
LinT, AmbasudhanR, YuanX, LiW, HilcoveS, AbujarourR, LinX, HahmHS, HaoE, HayekA and DingS. (2009). A chemical platform for improved induction of human iPSCs. Nat Methods, 6:805–808.
32.
SilvaJ, BarrandonO, NicholsJ, KawaguchiJ, TheunissenTW and SmithA. (2008). Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol, 6:e253.
33.
DelghandiMP, JohannessenM and MoensU. (2005). The cAMP signalling pathway activates CREB through PKA, p38 and MSK1 in NIH 3T3 cells. Cell Signal, 17:1343–1351.
34.
HannaJ, ChengAW, SahaK, KimJ, LengnerCJ, SoldnerF, CassadyJP, MuffatJ, CareyBW and JaenischR. (2010). Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc Natl Acad Sci U S A, 107:9222–9227.
35.
LaiWH, HoJCY, LeeYK, NgKM, AuKW, ChanYC, LauCP, TseHF and SiuCW. (2010). ROCK inhibition facilitates the generation of human-induced pluripotent stem cells in a defined, feeder-, and serum-free system. Cell Rep, 12:641–653.
36.
EstebanM, WangT, QinB, YangJ, QinD, CaiJ, LiW, WengZ, ChenJ, et al. (2010). Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell, 6:71–79.
37.
LiuY, SongZ, ZhaoY, QinH, CaiJ, ZhangH, YuT, JiangS, WangG, DingM and DengH. (2006). A novel chemical-defined medium with bFGF and N2B27 supplements supports undifferentiated growth in human embryonic stem cells. Biochem Biophys Res Commun, 346:131–139.
38.
HatoyaS, ToriiR, KondoY, OkunoT, KobayashiK, WijewardanaV, KawateN, TamadaH, SawadaT, et al. (2006). Isolation and characterization of embryonic stem-like cells from canine blastocysts. Mol Reprod Dev, 73:298–305.
39.
SchneiderMR, AdlerH, BraunJ, KienzleB, WolfE and KolbHJ. (2007). Canine embryo-derived stem cells—toward clinically relevant animal models for evaluating efficacy and safety of cell therapies. Stem Cells, 25:1850–1851.
40.
HayesB, FagerlieSR, RamakrishnanA, BaranS, HarkeyM, GrafL, BarM, BendoraiteA, TewariM and Torok-StorbB. (2008). Derivation, characterization, and in vitro differentiation of canine embryonic stem cells. Stem Cells, 26:465–473.
41.
VaagsAK, Rosic-KablarS, GartleyCJ, ZhengYZ, ChesneyA, VillagómezDA, KruthSA and HoughMR. (2009). Derivation and characterization of canine embryonic stem cell lines with in vitro and in vivo differentiation potential. Stem Cells, 27:329–340.
42.
NakagawaM, TaniguchiY, SendaS, TakizawaN, IchisakaT, AsanoK, MorizaneA, DoiD, TakahashiJ, et al. (2014). A novel efficient feeder-Free culture system for the derivation of human induced pluripotent stem cells. Sci Rep, 4:1–7.
43.
MüllerFJ, GoldmannJ, LöserP and LoringJF. (2010). A call to standardize teratoma assays used to define human pluripotent cell lines. Cell Stem Cell, 6:412–414.
44.
OrtmannD and VallierL. (2017). Variability of human pluripotent stem cell lines. Curr Opin Genet Dev, 46:179–185.
45.
Carcamo-OriveI, HoffmanGE, CundiffP, BeckmannND, D'SouzaSL, KnowlesJW, PatelA, PapatsenkoD, AbbasiF, et al. (2017). Analysis of transcriptional variability in a large human iPSC library reveals genetic and non-genetic determinants of heterogeneity. Cell Stem Cell, 20:518–532.
46.
ChhabraA, ChenIP and BatraD. (2017). Human dendritic cell-derived induced pluripotent stem cell lines are not immunogenic. J Immunol, 198:1875–1886.
47.
TrokovicR, WeltnerJ, NishimuraK, OhtakaM, NakanishiM, SalomaaV, JalankoA, OtonkoskiT and KyttäläA. (2014). Advanced feeder-free generation of induced pluripotent stem cells directly from blood cells. Stem Cells Transl Med, 3:1402–1409.
48.
AguCA, SoaresFA, AldertonA, PatelM, AnsariR, PatelS, ForrestS, YangF, LinehamJ, VallierL and KirtonCM. (2015). Successful generation of human induced pluripotent stem cell lines from blood samples held at room temperature for up to 48 hr. Stem Cell Reports, 5:660–671.
49.
MichaelPY, ScottAN and SusanLS. (2016). Raising the standards of stem cell line quality. Nat Cell Biol, 18:236–237.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
